Paper

Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.

Published Apr 30, 2020 · Xiangrong Song, Chao Liu, Ning Wang

Advanced drug delivery reviews

147

Citations

Influential Citations

Abstract

Abstract hidden due to publisher request; this does not indicate any issues with the research. Click the full text link above to read the abstract and view the original source.

Highly Cited

Study Snapshot

CRISPR/Cas systems show promise for cancer gene therapy and immunotherapy, but efficient and safe delivery through physical, viral, and non-viral vectors is crucial for clinical applications.

PopulationOlder adults (50-71 years)

Sample size24

MethodsObservational

OutcomesBody Mass Index projections

ResultsSocial networks mitigate obesity in older groups.

Delivery of CRISPR/Cas systems for cancer gene therapy and immunotherapy.

References

Citations